First-ever genomic test predicts which lung cancer patients need chemotherapy to live
Duke University Medical Center scientists have developed the first-ever genomic test to predict which patients with early-stage lung cancer will need chemotherapy to live and which patients can avoid the toxic regimen of drugs.